Microsoft MSFT shares have gained 17.9% year to date, outperforming the S&P 500, driven primarily by robust demand for its ...

Choice Equity Broking is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1010 in its research report dated November 07, 2025.